American National Bank & Trust’s DexCom DXCM Stock Holding History

American National Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9	Closed	-$597	–	645
2025 Q4	$597	Sell	9 -14	-61%	-$905	﹤0.01%	677
2025 Q3	$1.55K	Hold	23	–	–	﹤0.01%	612
2025 Q2	$2.01K	Sell	23 -13	-36%	-$1.02K	﹤0.01%	618
2025 Q1	$2.46K	Sell	36 -449	-93%	-$36.6K	﹤0.01%	544
2024 Q4	$37.7K	Buy	+485	New	+$35.9K	﹤0.01%	343
2022 Q4	–	Sell	-20	Closed	-$9K	–	636
2022 Q3	$9K	Buy	+20	New	+$1.69K	﹤0.01%	370
2022 Q2	–	Sell	-364	Closed	-$47K	–	440
2022 Q1	$47K	Buy	364 +92	+34%	+$10.1K	0.01%	187
2021 Q4	$37K	Buy	+272	New	+$39.1K	0.01%	207
2021 Q2	–	Sell	-44	Closed	-$4K	–	303
2021 Q1	$4K	Buy	+44	New	+$4.13K	﹤0.01%	239

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American National Bank & Trust's DXCM Position: Q1 2026 in Review

American National Bank & Trust sold out of DexCom (DXCM) in Q1 2026, closing a stake of 9 shares — an estimated $597 sold.

American National Bank & Trust first reported a position in DXCM in Q1 2021 and held it in 9 quarters. The position peaked at $47K in Q1 2022. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

American National Bank & Trust reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
American National Bank & Trust sold 9 DexCom shares in Q1 2026, an estimated $597.
American National Bank & Trust first reported a position in DexCom in Q1 2021 and held it in 9 quarters.
American National Bank & Trust's DexCom position peaked at $47K in Q1 2022.
959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on American National Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.